Ranbaxy, AstraZeneca Say Pay-For-Delay Deal Is Not Unlawful
Ranbaxy Inc. and AstraZeneca PLC urged a Massachusetts federal judge Monday to deny the plaintiffs' bid for a permanent injunction in Nexium antitrust multidistrict litigation nearly two months after a jury...To view the full article, register now.
Already a subscriber? Click here to view full article